Calcitonin treatment in hereditary bone dysplasia with hyperphosphatasemia: a radiographic and histologic study of bone.
Two children with bone dysplasia with hyperphosphatasemia (juvenile Paget's disease) were treated with synthetic human calcitonin. The progress of bone disease was monitored radiographically and histologically. Pretreatment radiographs showed markedly abnormal bone, characterized by lack of discrete cortex and absence of normal modeling. During treatment a discrete cortex was formed composed of compact bone, and more normal modeling occurred. This coincided with a histologic change from woven bone before treatment to a more lamellar type during treatment.
D000469:Alkaline Phosphatase / Q000097:blood*; D002116:Calcitonin / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005360:Fibula / Q000000981:diagnostic imaging; D006801:Humans; D006958:Hyperostosis, Cortical, Congenital / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D007223:Infant; D007866:Leg / Q000002:abnormalities; D008297:Male; D010011:Osteocytes / Q000502:physiology; D010014:Osteolysis / Q000473:pathology; D011859:Radiography; D013577:Syndrome; D013977:Tibia / Q000000981:diagnostic imaging
D002116:Calcitonin; D000469:Alkaline Phosphatase